市场调查报告书
商品编码
1467591
2024-2032 年 PET-CT 扫描仪设备市场报告(按类型、切片计数、同位素和探测器类型、服务提供者、应用程式和地区)PET-CT Scanner Device Market Report by Type, Slice Count, Isotope and Detector Type, Service Provider, Application, and Region 2024-2032 |
2023年,全球PET - CT扫描设备市场规模达22亿美元。由于生活方式的改变和环境因素导致癌症盛行率上升,不断增加的技术创新导致成像品质、效率和患者安全性提高,以及老年人口不断增长,该市场正在经历稳定增长。
市场成长与规模:由于医疗保健基础设施的改善以及先进影像技术投资的增加,市场正在稳步成长。
技术进步:人工智慧 (AI) 演算法和多模态成像功能的整合正在增强诊断能力并简化工作流程。
产业应用:PET-CT 扫描仪设备可用于心血管和神经系统疾病。
地理趋势:在新医院、诊断中心和专科诊所数量不断增加的推动下,亚太地区引领市场。然而,由于人们越来越意识到早期诊断的好处,北美正在成为一个快速成长的市场。
竞争格局:主要参与者正在投资研发 (R&D) 活动,以开发创新的 PET-CT 扫描仪技术,以提高影像能力、提高诊断准确性和病患舒适度。
挑战与机会:虽然市场面临初始成本高等挑战,但随着PET-CT影像应用的不断扩大,也遇到了机会。
未来展望:随着个人医疗保健需求的不断变化,PET-CT 扫描仪设备市场的未来前景广阔。此外,紧凑型便携式 PET-CT 扫描仪的不断发展将使 PoC 成像成为可能,预计这将促进市场成长。
癌症病例盛行率上升
世界各地癌症盛行率的不断上升正在推动 PET-CT 扫描仪设备市场的成长。 PET-CT 扫描仪在癌症诊断、分期和治疗监测中发挥关键作用。透过 PET-CT 影像进行早期检测可提高治疗效果和患者预后,从而促进其广泛采用。此外,医疗保健提供者越来越依赖 PET-CT 扫描来准确表征疾病并制定个人化治疗计划。这些扫描利用癌细胞选择性吸收的放射性药物,实现肿瘤内代谢活动的可视化。同时,CT 扫描提供详细的解剖影像,有助于精确定位 PET 检测到的异常代谢活动。从 PET-CT 扫描获得的全面资讯有助于肿瘤科医师就治疗策略(包括手术、放射治疗、化疗和标靶治疗)做出明智的决定。此外,PET-CT 扫描可以迅速开始治疗,并有可能改善患者的治疗效果。人们越来越需要改善获得先进诊断工具来对抗癌症的机会。
技术进步
PET-CT 扫描仪的创新有助于提高影像品质、效率和病患安全。现代 PET-CT 扫描仪具有更高的空间分辨率,可更清晰地显示小病灶,并提高肿瘤检测和表征的准确性。这项进步使得早期诊断和更精确的治疗计划成为可能。此外,先进的 PET-CT 扫描仪提供更短的扫描时间,有利于减少患者不适并提高医疗机构的工作流程效率。快速影像撷取使临床医生能够在一段时间内执行更多扫描,从而提高患者吞吐量并提高资源利用率。此外,PET-CT 技术的进步导致了辐射剂量较低、同时保持诊断影像品质的扫描仪的开发。这些扫描仪透过最大限度地减少患者的辐射暴露,提高了安全性,并降低了与重复成像研究相关的长期不良影响的风险。除此之外,PET-CT 扫描仪采用先进的运动校正技术,例如呼吸门控和运动跟踪,可确保影像更清晰、无伪影。
老年人口增加
由于全球老年人口不断增加,对 PET-CT 扫描仪设备的需求不断增长,对市场产生了积极影响。老年人更容易患癌症、阿兹海默症、心血管疾病和其他慢性疾病,因此需要先进的设备来准确检测和监测疾病。 PET-CT 扫描仪能够全面评估心臟功能、心肌灌注和活力,有助于老年患者心血管疾病的诊断和管理。此外,老化与神经退化性疾病的风险增加有关。 PET-CT 影像为大脑代谢、淀粉样蛋白沉积和神经受体结合提供了宝贵的见解,有助于老年人的早期诊断和疾病监测。除此之外,老年患者往往有多种合併症,需要全面的诊断评估。 PET-CT 扫描仪提供多模式影像功能,可在一次检查中同时评估多个器官系统。这种综合方法有利于简化诊断工作流程并增强管理老年人复杂健康状况的临床决策。
The global PET-CT scanner device market size reached US$ 2.2 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 3.1 Billion by 2032, exhibiting a growth rate (CAGR) of 3.62% during 2024-2032. The market is experiencing stable growth driven by rising prevalence of cancer due to lifestyle changes and environmental factors, increasing technological innovations that are leading to enhanced imaging quality, efficiency, and patient safety, and the growing geriatric population.
Market Growth and Size: The market is witnessing steady growth on account of the improving healthcare infrastructure, along with rising investments in advanced imaging technologies.
Technological Advancements: Integration of artificial intelligence (AI) algorithms and multimodal imaging capabilities is augmenting diagnostic capabilities and streamlining workflows.
Industry Applications: PET-CT scanner devices find applications in cardiovascular and neurological disorders.
Geographical Trends: Asia Pacific leads the market, driven by the rising number of new hospitals, diagnostic centers, and specialty clinics. However, North America is emerging as a fast-growing market due to the increasing awareness among individuals about the benefits of early diagnoses.
Competitive Landscape: Key players are investing in research and development (R&D) activities to develop innovative PET-CT scanner technologies with improved imaging capabilities, enhanced diagnostic accuracy, and patient comfort.
Challenges and Opportunities: While the market faces challenges, such as high initial costs, it also encounters opportunities on account of the expanding applications of PET-CT imaging.
Future Outlook: The future of the PET-CT scanner device market looks promising, with the evolving healthcare needs among individuals. Furthermore, the rising development of compact and portable PET-CT scanners will enable PoC imaging, which is anticipated to bolster the market growth.
Rising prevalence of cancer cases
The increasing prevalence of cancer among the masses around the world is propelling the PET-CT scanner device market growth. PET-CT scanners play a pivotal role in cancer diagnosis, staging, and treatment monitoring. Early detection through PET-CT imaging enhances treatment efficacy and patient outcomes, contributing to its widespread adoption. Moreover, healthcare providers are increasingly relying on PET-CT scans for accurate disease characterization and personalized treatment planning. These scans utilize radiopharmaceuticals that are selectively taken up by cancer cells, allowing for the visualization of metabolic activity within tumors. Meanwhile, CT scans provide detailed anatomical images that help precisely locate abnormal metabolic activity detected by PET. The comprehensive information obtained from PET-CT scans aids oncologists in making informed decisions regarding treatment strategies, including surgery, radiation therapy, chemotherapy, and targeted therapies. In addition, PET-CT scans enable prompt initiation of treatment and potentially improve patient outcomes. There is a rise in the need for improved access to advanced diagnostic tools to fight against cancer.
Technological advancements
Innovations in PET-CT scanners assist in enhancing imaging quality, efficiency, and patient safety. Modern PET-CT scanners feature higher spatial resolution that allows for clearer visualization of small lesions and improved accuracy in tumor detection and characterization. This advancement enables earlier diagnosis and more precise treatment planning. Moreover, advanced PET-CT scanners offer shorter scan times that benefit in reducing patient discomfort and enhancing workflow efficiency in healthcare settings. Rapid image acquisition enables clinicians to perform more scans in a time frame, leading to increased patient throughput and improved resource utilization. Furthermore, advancements in PET-CT technology are leading to the development of scanners with lower radiation doses while maintaining diagnostic image quality. These scanners improve safety and reduce the risk of long-term adverse effects associated with repeated imaging studies by minimizing radiation exposure to patients. Apart from this, PET-CT scanners employed with advanced motion correction techniques, such as respiratory gating and motion tracking, ensure sharper and artifact-free images.
Increasing geriatric population
The growing demand for PET-CT scanner devices due to rising geriatric population worldwide is positively influencing the market. Elderly individuals are more susceptible to cancer, Alzheimer's disease, cardiovascular disorders, and other chronic diseases, necessitating advanced devices that detect and monitor diseases accurately. PET-CT scanners enable comprehensive assessment of cardiac function, myocardial perfusion, and viability, aiding in the diagnosis and management of cardiovascular conditions in geriatric patients. Moreover, aging is associated with an increased risk of neurodegenerative disorders. PET-CT imaging provides valuable insights into brain metabolism, amyloid deposition, and neuroreceptor binding that facilitate early diagnosis and disease monitoring in elderly individuals. Apart from this, geriatric patients often have multiple comorbidities, requiring comprehensive diagnostic evaluations. PET-CT scanners offer multimodal imaging capabilities, allowing for simultaneous assessment of multiple organ systems in a single examination. This integrated approach benefits in streamlining diagnostic workflows and enhancing clinical decision-making in managing complex health conditions in the elderly.
IMARC Group provides an analysis of the key trends in each segment of the market, along with forecasts at the global, regional, and country levels for 2024-2032. Our report has categorized the market based on type, slice count, isotope and detector type, service provider, and application.
Stationary Scanners
Portable Scanners/Mobile Scanners
Stationary scanners account for the majority of the market share
The report has provided a detailed breakup and analysis of the market based on the type. This includes stationary scanners and portable scanners/mobile scanners. According to the report, stationary scanners represented the largest segment.
Low Slice Scanner (<64 Slices)
Medium Slice Scanner (64 Slices)
High Slice Scanner (>64 Slices)
Medium slice scanner (64 slices) holds the largest market share
A detailed breakup and analysis of the market based on the slice count have also been provided in the report. This includes low slice scanner (<64 slices), medium slice scanner (64 slices), and high slice scanner (>64 slices). According to the report, medium slice scanner (64 slices) accounted for the largest market share.
Flurodeoxyglucose (FDG)
62Cu ATSM
FMISO
Gallium
Thallium
Others
Flurodeoxyglucose (FDG) represents the leading market segment
The report has provided a detailed breakup and analysis of the market based on the isotope and detector type. This includes flurodeoxyglucose (FDG), 62Cu ATSM, 18 F sodium fluoride, FMISO, gallium, thallium, and others. According to the report, flurodeoxyglucose (FDG) represented the largest segment.
Hospitals
Diagnostic Centers
Research Institutes
Hospitals exhibit a clear dominance in the market
The report has provided a detailed breakup and analysis of the market based on the service provider. This includes hospitals, diagnostic centers, and research institutes. According to the report, hospitals represented the largest segment.
Oncology
Neurology
Cardiology
Others
Oncology dominates the market share
The report has provided a detailed breakup and analysis of the market based on the application. This includes oncology, neurology, cardiology, and others. According to the report, oncology represented the largest segment.
North America
United States
Canada
Asia-Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa
Asia Pacific leads the market, accounting for the largest PET-CT scanner device market share
The market research report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, Asia Pacific accounted for the largest market share due to the presence of well-established new hospitals, diagnostic centers, and specialty clinics. In addition, the rising prevalence of cancer among individuals in the region is bolstering the market growth.
Bruker Corporation
Canon Medical Systems Usa Inc.
General Electric Company
Hitachi Ltd.
Koninklijke Philips N.V.
Mediso Ltd.
Neusoft Corporation
Positron Corporation
Shimadzu Corporation
Siemens Healthcare GmbH (Siemens AG)
Sofie Biosciences Inc.
United Imaging Healthcare Co. Ltd.
Yangzhou Kindsway Biotech Co. Ltd.